🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesSURPASS-CVOT: tirzepatide cardiovascular outcomes trial design — looking for input Page 7

SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design — looking for input

Admin Sat, Jul 12, 2025 at 7:09 AM 40 replies 1,896 viewsPage 7 of 8
marco_milano
Member
345
1,456
Jul 2024
Milan, IT
Jul 12, 2025 at 5:04 PM#31

Saving this for reference. Top-tier content.

36 2kevin_tulsa, Dr.PainCLE, mike_mealprep and 33 others
Reply Quote Save Share Report
Dr.LeslieOBGYN
Member
567
2,567
May 2024
Dallas, TX
Jul 12, 2025 at 5:21 PM#32
Dr.RaviCardio said:
5%, triglycerides 249 → 119 mg/dL, hsCRP 8

This is exactly right. Dr.RaviCardio articulated what I have been trying to explain to my friends for months. The SURPASS-CVOT tirzepatide aspect is what made the difference for me.

Last edited: Jul 12, 2025 at 11:21 PM
6 6FranDenver, Dr.BariatricHTX, LindaRN_retired and 3 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jul 12, 2025 at 5:38 PM#33

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on SURPASS-CVOT tirzepatide.

To answer Admin: my doctor and I discussed the options and went with brand.

Quick update: I have noticed more improvement since posting this. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

23 24RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 20 others
Reply Quote Save Share Report
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Jul 12, 2025 at 5:55 PM#34
Dr.SportsMedIN said:
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new

This is exactly right. Dr.SportsMedIN articulated what I have been trying to explain to my doctor for months. The SURPASS-CVOT tirzepatide aspect is the most important factor.

Last edited: Jul 12, 2025 at 10:55 PM
33 9Dr.PeteFamMed, claudia_zurich, nancy_portland and 30 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Jul 12, 2025 at 6:12 PM#35

Subscribing to this thread. SURPASS-CVOT tirzepatide is exactly what I've been researching. 🙏

Last edited: Jul 12, 2025 at 11:12 PM
43 24hank_denver, carlos_SATX, sophie_paris and 40 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register